Tatva Chintan Pharma Chem Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The filing discloses a standalone turnover of ₹4,962.96 million and a net worth of ₹7,582.29 million.

The company operates in the specialty chemicals sector, with exports contributing 75% of its total turnover. Its primary business activities include the manufacturing of Structure Directing Agents, Phase Transfer Catalysts, and Pharmaceutical and Agrochemical Intermediates.

Business Performance and Operations

The entity reported its financial position based on standalone figures. The paid-up capital stands at ₹233.92 million. The company maintains two manufacturing plants and two offices within India, serving customers across 17 states domestically and 30 countries internationally.

Environmental Metrics

The report details significant environmental data points for FY26 compared to the previous year. Total energy consumption from non-renewable sources rose to 285,897.23 Gigajoules, up from 206,466.60 Gigajoules in FY25. This increase coincided with a rise in Scope 1 greenhouse gas emissions to 10,637.93 t CO₂ eq. from 7,661.79 t CO₂ eq.

Water withdrawal increased to 122,859 kiloliters, entirely sourced from third parties, compared to 83,554 kiloliters in the prior year. The Ankleshwar manufacturing unit continues to operate as a Zero Liquid Discharge facility since January 2020.

Social and Governance Disclosures

The company employs 363 permanent employees and 734 workers. The workforce is predominantly male, with women constituting 6.06% of permanent employees and 0.27% of workers. The turnover rate for permanent employees was 49.79% in FY26, an increase from 30.06% in FY25.

No complaints were received regarding sexual harassment, child labor, or forced labor during the reporting period. The company reported 14 customer complaints, all of which were resolved by the end of the year. There were no instances of fines or penalties paid to regulators or law enforcement agencies.

What the Numbers Show

The divergence between rising operational inputs and stable efficiency metrics warrants attention. While total energy consumption jumped significantly to 285,897.23 GJ from 206,466.60 GJ, the energy intensity per rupee of turnover remained nearly flat, moving from 0.0000563 to 0.0000576. This suggests that the substantial increase in absolute energy usage was largely absorbed by proportional growth in production volume or revenue, rather than indicating a decline in operational efficiency.

Tatva Chintan Pharma Chem Limited has accepted the resignation of Mr. Ajay Rawat, who served as Assistant Vice President – Research and Development. The company disclosed that Mr. Rawat submitted his resignation letter on August 14, 2026, citing personal career opportunities as the reason for his departure.

The management formally accepted the resignation on August 19, 2026. Mr. Rawat’s exit will become effective from the close of business hours on November 13, 2026. During this transition period, he will continue to perform his duties as a Senior Management Personnel of the company.

Regulatory Disclosure

The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure also references SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026, which was issued on July 11, 2023, and last updated on January 30, 2026.

The complete disclosure, including Annexure A and a copy of the resignation letter, is available on the company’s website at www.tatvachintan.com . Ishwar Nayi, Company Secretary and Compliance Officer, signed the communication to the stock exchanges.